Sally Hall

Doctor of Medicine,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Case Consulting Grant Submission Career Advice and Mentoring

Areas Of Interest

Conjugated Estrogenic Substances Paramecium aurelias Caseins Delta-6 Fatty Acid Desaturase Metalloproteinase, Membrane-Type Matrix Terpenoid Indole Alkaloids Rumination Disorders Benign Hereditary Choreas Vertebrobasilar Circulation Transient Ischemic Attack Fibroblast Derived Induced Pluripotent Stem Cells Fusions, Nuclear Tolerance, Impaired Glucose Program Efficiencies D-Ala-D-Ala Carboxypeptidases, Serine-Type Systemic Mastocytoses Traumatic Sixth-Nerve Palsy Mobile Hospitals echovirus 23s, Human Infarction, Anterior Cerebral Artery Distribution Diatrizoate Transporter, DAT Dopamine Liver Cell Adenoma Thyroarytenoid Muscles SCA2 Protein Hyperlipidemia, Multiple Lipoprotein Type Fats, Beige Brite Porcine Gastroenteritides, Transmissible Multiple Cartilaginous Exostosis Nerves, Inferior Hemorrhoidal CL-232325 brasiliensis, Leishmania Prolyl-Leucyl-Glycinamide Acylations, Transfer RNA CEL1 Protein c-raf Kinases Jicama Footprints, Protein Infectious Anemias, Equine

Professional Narrative

Dr. Sally Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 1999
Medical Writer, Harvard Med 2004

Education

Doctor of osteopathic medicine, Perelman School of Medicine 1988
Director Medicine, Yale School of Medicine 2004

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :